Biotechnology in surgery: polypropylene meshes incorporated with chitosan and antibiotics in the treatment of peritoneotomy in rats - preliminary study
International Journal of Development Research
Biotechnology in surgery: polypropylene meshes incorporated with chitosan and antibiotics in the treatment of peritoneotomy in rats - preliminary study
Received 03rd January, 2022 Received in revised form 11th February, 2022 Accepted 09th March, 2022 Published online 22nd April, 2022
Copyright©2022, Rodrigo Wasem Galia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: Surgical meshes are common in peritoneostomies to control damage and reduce mortality in critically ill patients. The use of chitosan provides anti-adherence to the polypropylene mesh and the addition of antibiotics reduces the rate of infections. Objective: To create and test biocompatible film involving chitosan associated or not with antibiotics, by nanotechnology, and to identify adhesions when in direct contact with the abdominal viscera. Methods: In vivo experimentation in Wistar rats, with random division, according to the Reduce, Refine and Replace principles. In two of the four groups, there was an association of antimicrobial on the mesh. One animal from each group had the greater omentum removed. In the end, the animals were killed without suffering. Results: There was no adhesion between the polypropylene mesh and the viscera. Granulation tissue and total incorporation of the material under test were observed, indicative of biocompatibility. Two animals in the group without antibiotics developed ulceration. Discussion: The sustainable and low-cost experiment represents an advance in Biotechnology and an alternative in the care of patients undergoing peritoniostomy, after industrial refinement. Conclusion: Polypropylene meshes with chitosan proved to be effective in terms of non-visceral adherence. Even without the great omentum, there was no rejection, demonstrating the biocompatibility of the nanotechnology used.